SCHEMBL6154794

SCHEMBL6154794

NNC(=O)c1ccc(Br)c(Cl)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.57
ALDH1A1 P00352 7/20 0.55
KDM4E B2RXH2 7/20 0.55
LMNA P02545 2/20 0.55
OGG1 O15527 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
GAA P10253 1/20 0.50
MPO P05164 1/20 0.47
CYP3A4 P08684 1/20 0.47
KDM5A P29375 1/20 0.47
BLM P54132 1/20 0.47
GFER P55789 1/20 0.47
PMP22 Q01453 1/20 0.47
HIF1A Q16665 1/20 0.47
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA9 Q16790 1/20 0.46
HPGD P15428 3/20 0.45
POLB P06746 1/20 0.45
HTT P42858 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6154331 0.85 KDM4E (0.55) MAPTALDH1A1KDM4ELMNAOGG1
SCHEMBL1202191 0.82 HPGD (0.62) MAPTALDH1A1KDM4ELMNAL3MBTL1
SCHEMBL29994706 0.82 HPGD (0.62) MAPTALDH1A1KDM4ELMNAL3MBTL1
Hydrochloric Acid SCHEMBL155794 0.81 HPGD (0.61) MAPTALDH1A1KDM4ELMNAL3MBTL1
SCHEMBL26785504 0.81 MAPT (0.53) MAPTALDH1A1KDM4ELMNAL3MBTL1
SCHEMBL22325377 0.79 ALDH1A1 (0.57) MAPTALDH1A1KDM4ELMNAOGG1
SCHEMBL1363239 0.79 KDM4E (0.57) MAPTALDH1A1KDM4ELMNAOGG1
SCHEMBL1460363 0.79 KDM4E (0.70) MAPTALDH1A1KDM4ELMNAOGG1
SCHEMBL24671107 0.79 MAPT (0.90) MAPTALDH1A1KDM4ELMNAL3MBTL1
SCHEMBL29803936 0.79 MAPT (0.90) MAPTALDH1A1KDM4ELMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US disclosed
EP-1446110-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES Structural Bioinformatics Inc. (US) 2004-08-18 EP disclosed
WO-2003032916-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES STRUCTURAL BIOINFORMATICS INC. (US) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases PTPRS, PTPRJ, PTPRCAP MAPT 3318/4885ALDH1A1 961/4885KDM4E 1133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.